Newsletter Subscription

Enter Name and Email

07 March 2012 - Adrian to present at AFPBN meeting in Paris

Adrian Newman-Tancredi Ph.D. will be presenting at a session of the Association Française de Psychiatrie Biologique et de la Neuropsychopharmacologie (AFPBN) taking place in Paris from 15th to 17th March 2012. The session will be sponsored by AstraZeneca Pharmaceuticals and focus on the use and mechanism of action of antipsychotics in bipolar depression, with particular reference to quetiapine (Seroquel ®). The latter's metabolite, norquetiapine, possesses a distinctive profile of activity, inhibiting noradrenaline reuptake and activating serotonin 5-HT1A receptors.
Adrian has extensive experience of antipsychotics pharmacology and drug discovery and has presented to a wide variety of audiences.
If you are attending the conference, Adrian would be happy to meet with you: Contact.


Friday, 16th March 2012, 12h30 – 14h00, Palais Brongniart, Paris.

Chairperson : Prof. Michel Hamon


Philippe Courtet: "Troubles bipolaires: vers une approche translationnelle"

Adrian Newman-Tancredi: "Psychopharmacologie des monoamines"

Pierre Michel Llorca: "Antipsychotiques et dépression bipolaire: des hypothèses à la clinique"


For full details of the AFPBN meeting click here.